Merck & Co., Joins Atriax Advisory Board

Merck & Co., the global pharmaceuticals firm, has joined the advisory board of Atriax, the multi-bank foreign exchange portal. The Atriax Advisory Board now consists of twenty-five global corporations and financial institutions and represents the interests of price-takers in the design and development of Atriax. Atriax is the multi-bank foreign exchange portal backed by Citibank, Deutsche Bank, JP Morgan and Reuters.


Related reading